VeriMomIst di-c12-15 pareth-4 phosphate in der Schwangerschaft sicher?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
Pregnancy-safe products containing di-c12-15 pareth-4 phosphate
Related ingredients
Frequently asked questions
- Ist di-c12-15 pareth-4 phosphate in der Schwangerschaft sicher?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
- Ist di-c12-15 pareth-4 phosphate während des Stillens sicher?
- Same rationale as pregnancy: no authoritative reproductive/breast‑milk transfer hazards identified. Low but measurable systemic exposure from topical use is possible but no data demonstrating transfer in milk. Sources: ECHA Annex VI, PubChem, CosIng; no SCCS/CIR hazard finding.
- Ist di-c12-15 pareth-4 phosphate sicher für Babyhaut?
- No infant-specific reproductive or developmental toxicity data found. Because infant skin has a higher surface‑area‑to‑weight ratio and an immature barrier, topical exposure was up‑rated by +1 relative to adult exposure (adult e=1 → infant e=2). No evidence indicates increased mechanistic hazard for infants. Sources: CosIng/PubChem for ingredient use and identity; no SCCS/CIR concerns or ECHA harmonised classification.
- Wie bewertet VeriMom di-c12-15 pareth-4 phosphate?
- VeriMom bewertet di-c12-15 pareth-4 phosphate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu di-c12-15 pareth-4 phosphate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu di-c12-15 pareth-4 phosphate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.